title: Breast cancer prevention in the era of precision medicine.
authors: Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. steven.narod@wchospital.ca.
authors: Steven A
authors: SA
authors: Narod
mesh_terms: D016588:Anticarcinogenic Agents / Q000008:administration & dosage; D024682:BRCA2 Protein / Q000235:genetics*; D001943:Breast Neoplasms / Q000235:genetics / Q000401:mortality / Q000517:prevention & control*; D002170:Canada / Q000453:epidemiology; D055088:Early Detection of Cancer / Q000379:methods*; D005260:Female; D005820:Genetic Testing; D055106:Genome-Wide Association Study; D006801:Humans; D019458:Insurance Coverage; D015411:Mastectomy, Modified Radical / Q000379:methods / Q000706:statistics & numerical data*; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D057285:Precision Medicine; D018570:Risk Assessment; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage; D015996:Survival Rate; D013629:Tamoxifen / Q000008:administration & dosage; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
chemical_list: D016588:Anticarcinogenic Agents; D024682:BRCA2 Protein; C551750:BRCA2 protein, human; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen